| Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction (NCT01547598) | Allergan | 2011-12-01 |
| Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT01489670) | Allergan | 2011-09-01 |
| Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost (NCT01430923) | Aurolab | 2011-09-01 |
| Glaucoma Eye Drop Instillation: Impact of Education (NCT01416415) | Northwestern University | 2011-08-01 |
| Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma (NCT02376114) | Maisonneuve-Rosemont Hospital | 2011-08-01 |
| A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension (NCT02020512) | Allergan | 2011-07-01 |
| Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT01291108) | Allergan | 2011-04-01 |
| Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT01241240) | Allergan | 2011-03-01 |
| Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT01217606) | Allergan | 2011-01-01 |
| SOLX Gold Shunt for Refractory Glaucoma (NCT01282346) | SOLX, Inc. | 2011-01-01 |
| Assessment of Effectiveness Ex-Press Surgery Modification (NCT03800589) | Military Institute od Medicine National Research Institute | 2010-12-01 |
| Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT01253902) | Allergan | 2010-12-01 |
| A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01628614) | Allergan | 2010-11-01 |
| Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT01215786) | Allergan | 2010-10-01 |
| Saccadic Eye Movements Are Impaired In Glaucoma (NCT01254058) | Unity Health Toronto | 2010-07-01 |
| A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension (NCT02003534) | Allergan | 2010-07-01 |
| Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated (NCT01243567) | Allergan | 2010-06-01 |
| GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy (NCT01628601) | Allergan | 2010-05-01 |
| A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension (NCT02061683) | Allergan | 2010-04-19 |
| Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01628588) | Allergan | 2010-03-01 |
| A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01632423) | Allergan | 2010-02-01 |
| A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 (NCT00934089) | Pfizer | 2010-01-01 |
| Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution (NCT01001195) | Allergan | 2009-11-01 |
| Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea (NCT01976624) | Allergan | 2009-08-01 |
| A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years (NCT01629407) | Allergan | 2009-06-01 |
| Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) (NCT00913029) | Glaukos Corporation | 2009-05-01 |
| A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma (NCT00911924) | Glaukos Corporation | 2009-05-01 |
| A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy (NCT01637246) | Allergan | 2009-04-01 |
| Safety and Efficacy of Combigan® Ophthalmic Solution in Korea (NCT01987752) | Allergan | 2009-01-01 |
| Safety and Efficacy of a Glaucoma Drug Delivery System (NCT00824720) | Vistakon Pharmaceuticals | 2008-12-01 |
| Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00804648) | Vistakon Pharmaceuticals | 2008-11-01 |
| Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy. (NCT00801437) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-10-01 |
| Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma (NCT00753168) | Othera Pharmaceuticals | 2008-09-01 |
| Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada (NCT00334750) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-11-01 |
| Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® (NCT00486252) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-06-01 |
| Intraocular Pressure With Loteprednol and Dexamethasone (NCT00781300) | Federal University of São Paulo | 2006-03-01 |
| Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition (NCT00306657) | Kantonsspital Aarau | 2006-03-01 |
| Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells (NCT00410267) | University of Pittsburgh | 2006-02-01 |
| Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments. (NCT00347191) | Aston University | 2006-01-01 |
| A Long-term Safety Study of Once-daily Travatan (NCT00051168) | Alcon Research | 2006-01-01 |
| SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma (NCT00382395) | SOLX, Inc. | 2005-11-01 |
| A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma (NCT00159653) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07-01 |
| A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma (NCT00140049) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07-01 |
| SOLX Titanium Sapphire Laser for Trabeculoplasty (NCT00145535) | SOLX, Inc. | 2004-05-01 |
| A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma (NCT00647101) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-12-01 |
| A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00311389) | Alcon Research | 2003-01-01 |
| Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma (NCT00487214) | Allergan | 2002-06-01 |
| A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension (NCT00150267) | Pfizer | 2002-02-01 |
| Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. (NCT00140062) | Pfizer | 2002-02-01 |
| A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) (NCT00051142) | Alcon Research | 2001-02-01 |
| A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) (NCT00051155) | Alcon Research | 2001-01-01 |
| Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes (NCT00707226) | Medical University of Vienna | 2000-11-01 |
| Treatment of Failing Blebs With Ranibizumab (NCT00570726) | The New York Eye & Ear Infirmary | 2000-06-01 |
| A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma (NCT00991822) | Medical University of Vienna | 1999-05-01 |
| Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma (NCT00317577) | Chicago Center for Vision Research | 1998-12-01 |
| Pigment Dispersion Syndrome With and Without Glaucoma (NCT00001152) | National Eye Institute (NEI) | 1976-06-01 |
| Corneal Versus Conjunctival Delivery Using a Delivery Device (NCT00143429) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |
| Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon Laser Trabeculoplasty in Open-Angle Glaucoma Patients (NCT00470964) | Goldschleger Eye Institute | |
| Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device (NCT00283764) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | |